Header
SABPA Newsletter, October 2017
In This Issue
Upcoming Events
20th SABPA Entrepreneur Symposium
Connect With Us
 
Subscribe to our WeChat 

SABPA Events

The 20th SABPA Entrepreneur Symposium
IP Strategies to Maximize Protection of Biotech and Pharmaceutical Products
When: 5:30 pm to 8:00 pm, Tuesday, October 10th, 2017
 
 
Free online registration by Sunday, Oct 6th, 2017 (limit 70 attendees); $10 onsite registration

Scan to register


Organizers:
SABPA Entrepreneur Committee, event chairs: Annie Mak, PhD, Jie Jiang, PhD
Jones Day – One Firm Worldwide, Contact: Lin Yu, PhD, Esq, LYU@jonesday.com, (858)314-1128
Speakers and Seminar Abstracts
 

Dr. Dale L. Rieger is a patent attorney and partner at Jones Day. Dr. Rieger counsels clients in all aspects of patent portfolio development, particularly in the field of chemistry including pharmaceuticals, agrochemicals, and polymers. He advises pharmaceutical and biotechnology companies regarding pharmaceutical life cycle management and Hatch-Waxman patent term extensions and litigation. He also advises corporate and venture investors on intellectual property due diligence associated with mergers and acquisitions, joint ventures, private and public financings, and initial public offerings. Dr. Rieger’s legal and scientific career has emphasized pharmaceuticals, particularly working with small molecule drugs. Before joining Jones Day, he worked at Agouron Pharmaceuticals as a senior scientist, at Gensia as a senior research scientist, and at Merck Research Laboratories as a senior research chemist. Dr. Rieger received a Ph.D. in Organic Chemistry from Indiana University and was a postdoctoral fellow at Harvard. Dr. Rieger will discuss patent portfolio management and Orange Book listing of small-molecule drug patents.

Dr. Cary Miller is a patent attorney and partner at Jones Day. With more than 15 years of experience, Dr. Miller’s practice focuses on assisting life sciences clients with their patent issues. She works with clients in patent prosecution, prelitigation analysis, PTAB proceedings, and patent litigation. Dr. Miller’s currently represents Celgene in several Hatch-Waxman patent litigations involving the pharmaceuticals Abraxane®, Pomalyst®, and Revlimid®. Previously, Dr. Miller’s participated in numerous biotechnology and pharmaceutical patent lawsuits including representing companies in Hatch-Waxman litigation, biosimilars litigation, and in litigation relating to DNA sequencing. She has successfully litigated patent cases throughout the United States, including in California, New Jersey, New York, Delaware, Texas, and Nevada and before the Federal Circuit and Supreme Court.  Dr. Miller has drafted and prosecuted patents relating to breakthrough therapies in a number of areas, including antibodies and antibody-drug conjugates, cancer therapeutics and diagnostics, small molecules, human embryonic stem cells, and drug delivery devices. She has conducted intellectual property due diligence studies and has filed numerous patent term extension applications for drugs, biologics, and medical devices. Dr. Miller received a Ph.D. in in cellular, developmental, and molecular biology from Mount Sinai School of Medicine.  Dr. Miller will discuss patent term extension (PTE) and FDA exclusivities.

Agenda:
5:30 to 6:20 pm:     Registration and Networking dinner
6:20 to 6:30 pm:     Welcome by Peter Huang, PhD, In-coming President of SABPA
6:30 to 7:30 pm:     Dr. Dale L. Rieger Patent portfolio management and Orange Book listing of small-molecule drug patents
Dr. Cary Miller Patent term extension (PTE) and FDA exclusivities
7:30 to 8:00 pm:     Networking

The Third SABPA-UCSD Career Development Forum
Panel Discussion:  “Inside the Hiring Managers’ Mind”
While many postdocs are interested in career opportunities in the biotech and pharmaceutical industry, it remains very challenging to navigate the application process and understand what it actually takes to obtain an industry position. In the 3rd Annual Joint Career Development Forum co-organized by SABPA Education & Career Development (ECD) Committee and UCSD Postdoc Association (PDA), we have invited HR specialists and hiring managers who have hired candidates at various career stages from local life science industry to form an interactive panel, sharing with the audience their perspectives of the industry hiring process and discussing the qualifications, experience and many other qualities of the successful candidates.
When:    Wednesday, November 1st, 2017, 5:30 – 8:30pm
Registration: Opening Soon!
Agenda: 
5:30 – 6:00pm Registration & Networking
6:00 – 6:30pm Dinner & Networking
6:30 – 8:00pm Panel discussion
8:00 – 8:30pm Networking & Wrap up

SABPA Announcement
Outcome of the 2017 SABPA Board of Directors Election
The SABPA Board of Directors (BOD) is the governing body that oversees the activities of SABPA organization. There are twenty-one (21) board directors for a three-year term. In 2017, seven (7) director seats were open for candidates seeking re-election and new election. Nine (9) SABPA member-nominated and qualified candidates entered the election this year. Based on the votes, the following candidates were elected as board directors (alphabetical order) in 2017: Hui Li, Ming Guo, Peter Zhu, Stephanie Shi, Xuefeng Zhu, Yahu Liu, and Yinghong Gao.
The 2017 SABPA BOD Election Committee sincerely thank all candidates for their strong leadership and remarkable contribution to SABPA’s success and their participation in 2017 SABPA BOD election. The committee is also grateful to SABPA members for the involvement.
Please see below the complete list of all of the current board members and the executive committee.
Mingzhu Zhang
Chair

Affiliation: Medicilon

Stephanie Shi
Vice Chair

Affiliation: Pfizer

Yahu Liu
Vice Chair

Affiliation: GNF, Novartis

Huaina Li
Vice Chair

Affiliation: B.Braun Medical Inc.

Jinsong Ni
Vice Chair

Affiliation: Cloudbreak Therapeutics

Other board members:

First Name
Last Name
Affiliation
Guang
Chen
J&J
Yinghong
Gao
Pharmaron
Hua
Gong
Navigate BioPharma (Novartis)
Ming
Guo
Ascentage Pharma
Peter
Huang
Zeno
Shuangwei
Li
Wellspring Biosciences
Hui
Li
Sorrento Therapeutics
Yi
Liu
Wellspring Biosciences
Yang
Liu
Sanford-Burnham Medical Research Institute
Fred
Ouyang
Alan Laboratories, Inc.
Weijun
Shen
California Institute for Biomedical Research
Tao
Wu
Wellspring Biosciences
JC
Xu
Celgene Quanticel Research
Yan-Bo
Yang
BioPharmaDev, Inc.
Peter
Zhu
Pfizer
Xuefeng
Zhu
GNF
Congratulations to re-elected and newly elected directors!
2017 SABPA BOD Election Committee

Our Platinum Corporate Sponsors

Our Gold Corporate Sponsors
About SABPA
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
Our Mission
  • Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
  • Foster professional growth, career improvement and personal development of our members;
  • Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
  • Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
  • To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.
SABPA.org, P.O. BOX 927631, San Diego, CA 92192